Bill Maughan

Stock Analyst at Clear Street

(0)
# 4919
Out of 5,386 analysts
15
Total ratings
Success rate
Average return
Main Sectors:
Top Industries:
9 Stocks
Name Action PT Current % Upside Ratings Updated
CRSP CRISPR Therapeutics
Downgrades: Hold
45
47.45 -5.16% 1 Jun 27, 2025
YMAB Y-mAbs Therapeutics
Maintains: Buy
26 26
4.74 448.52% 2 Aug 13, 2024
NKTX Nkarta
Maintains: Buy
16 15
1.67 798.2% 2 May 10, 2024
FATE Fate Therapeutics
Maintains: Buy
11 9
1.03 773.79% 1 May 10, 2024
IMCR Immunocore Hldgs
Maintains: Hold
63 67
31.15 115.09% 3 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
91 106
27.17 290.14% 3 May 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 24
0.53 4428.3% 1 Mar 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
60
7.23 729.88% 1 Feb 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
45
52.94 -15% 1 Nov 2, 2023